{"id":"W2958757303","doi":"10.1007/s40265-019-01169-y","title":"Innovations in Oral Therapies for Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Vedolizumab; Infliximab; Drug development; Tofacitinib; Internal medicine; Adverse effect; Pharmacology; Drug; Disease; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002492714,0.0003695025,0.0004838953,0.0001807733,0.00005137082,0.00003583526,0.0003478764,0.0002897723,0.00002233534],"category_scores_gemma":[0.0001158186,0.00034166,0.0003946822,0.0001215706,0.00006677274,0.000006015785,0.0001178454,0.0001487603,0.00008601207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005013539,"about_ca_system_score_gemma":0.0009070656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001447407,"about_ca_topic_score_gemma":0.000009848685,"domain_scores_codex":[0.9984757,0.0001059718,0.0004992189,0.0004822889,0.0001227165,0.0003141508],"domain_scores_gemma":[0.9988688,0.00002884924,0.0002206165,0.0006773784,0.0001000755,0.0001043426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004875009,0.0003771989,0.002777048,0.07428234,0.0008869781,0.0001279223,0.0003037277,0.00003950444,0.00005915515,0.006902298,0.02541607,0.8883402],"study_design_scores_gemma":[0.0004149451,0.00001499669,0.0009144006,0.0009415091,0.0001693028,8.335685e-7,0.00001879455,0.000007807885,0.000001937582,0.00009072285,0.997013,0.0004118033],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002008979,0.9950423,0.00003786206,0.00002474533,0.0003241893,0.001776857,0.0004404164,0.00002238504,0.0003223183],"genre_scores_gemma":[0.0003352023,0.9931804,0.0001200825,0.0002009493,0.00036209,0.001052292,0.002789772,0.0001150697,0.001844132],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9715969,"threshold_uncertainty_score":0.9999036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02364530140684572,"score_gpt":0.3107230209837264,"score_spread":0.2870777195768807,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}